Quality of life in patients with thalassemia intermedia compared to thalassemia major

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 457-461

  Pakbaz, Zahra ^a   Treadwell, Marsha ^a   Yamashita, Robert ^a   Quirolo, Keith ^a   Foote, Drucilla ^a   Quill, Laura ^b   Singer, Titi ^a   Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Quality of life; Thalassemia

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ANXIETY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DARTMOUTH PRIMARY CARE COOPERATIVE INFORMATION CHART SYSTEM QUESTIONNAIRE; DEPRESSION; DETERIORATION; DISEASE SEVERITY; DRUG TRANSFORMATION; EVALUATION; FEMALE; HEALTH STATUS; HUMAN; MALE; MEDICAL RECORD; POOR GENERAL CONDITION; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR;

EID: 29744442891     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.059     Document Type: Conference Paper

References (21)

1. BRITTENHAM, G.M., P.M. GRIFFITH, A.W. NIENHUIS, et al. 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med. 331: 567-573.
2. CAPELLINI, N., C.A. ELEFTHERIOU, A. PIGA & J. PORTER. 2000. Guidelines for the Clinical Management of Thalassemia, 3rd ed. Thalassemia International Federation, Nocosia, Cyprus, pp. 21-24.
3. OLIVIERI, N.F. & G.M. BRITTENHAM. 1997. Iron-chelating therapy and the treatment of thalassemia. Blood 89: 739-761.
4. MIKELLI, A. & J. TSIANTIS. 2004. Brief report: depressive symptoms and quality of life in adolescents with β-thalassaemia. J. Adolesc. 27: 213-216.
5. POLITIS, C. 1998. The psychosocial impact of chronic illness. Ann. N.Y. Acad. Sci. 850: 349-354.
6. RATIP, S., D. SKUSE, J. PORTER, et al. 1995. Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis. Arch. Dis. Child 72: 408-412.
7. TSIANTIS, J., T. DRAGONAS, C. RICHARDSON, et al. 1996. Psychosocial problems and adjustment of children with beta-thalassemia and their families. Eur. Child Adolesc. Psychiatry 5: 193-203.
8. CHAIDOS, A., A. MAKIS, E. HATZIMICHAEL, et al. 2004. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. Acta Haematol. 111: 189-195.
9. DIXIT, A., T.C. CHATTERJEE, P. MISHRA, et al. 2005. Hydroxyurea in thalassemia intermedia-a promising therapy. Ann. Hematol. 84: 441-446.
10. LAL, A. & E. VICHINSKY. 2004. The role of fetal hemoglobin-enhancing agents in thalassemia. Semin. Hematol. 41(Suppl. 6): 17-22.
11. PAKBAZ, Z., E. FUNG, N. SWEETERS, et al. 2003. Low bone mass in patients with thalassemia. Blood 102: 38b.
12. PAKBAZ, Z., R. FISCHER, E. FUNG, et al. 2004. Serum ferritin underestimates the severity of iron overload in not regularly transfused thalassemia patients. In Proc. 17th Annu. Meet, of American Society of Pediatrie Hematology-Oncology. San Francisco.
13. AESSOPOS, A., G. STAMATELOS, V. SKOUMAS, et al. 1995. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest 107: 50-53.
14. AESSOPOS, A., D. FARMAKIS, M. KARAGIORGA, et al. 2001. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97: 3411-3416.
15. NELSON, E., J. WASSON, J. KIRK, et al. 1987. Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings. J. Chronic Dis. 40(Suppl 1): 55S-69S.
16. NELSON, E.C., J.M. LANDGRAF, R.D. HAYS, et al. 1990. The functional status of patients. How can it be measured in physicians' offices? Med. Care 28: 1111-1126.
17. PATERSON, C. 2004. Seeking the patient's perspective: a qualitative assessment of EuroQol, COOP-WONCA charts and MYMOP. Qual. Life Res. 13: 871-881.
18. DETMAR, S.B., M.J. MULLER, J.H. SCHORNAGEL, et al. 2002. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288: 3027-3034.
19. WONG-CHUNG, D., N. MATEIJSEN, R. WEST, et al. 1991. Assessing the functional status during an asthma attack with Dartmouth COOP charts. Validity with respect to the change in asthma. Fam. Pract. 8: 404-408.
20. MCHORNEY, C.A., J.E. WARE, JR., W. ROGERS, et al. 1992. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med. Care 30(Suppl.): MS253-MS265.
21. BRUUSGAARD, D., I. NESSIOY, O. RUTLE, et al. 1993. Measuring functional status in a population survey. The Dartmouth COOP functional health assessment charts/WONCA used in an epidemiological study. Fam. Pract. 10: 212-218.